The Discounted Cash Flow (DCF) valuation of Ose Immunotherapeutics SA (OSE.PA) is (23,564.52) EUR. With the latest stock price at 7.80 EUR, the upside of Ose Immunotherapeutics SA based on DCF is -302209.2%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 7.3% | 6.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (82,514.25) - (13,849.66) | (23,564.52) |
| Upside | -1057975.0% - -177659.7% | -302209.2% |